Onconetix, Inc. (ONCO)
0.656
+0.01
(+0.85%)
USD |
NASDAQ |
Aug 24, 16:00
0.65
-0.01
(-0.91%)
After-Hours: 04:30
Onconetix Shareholders Equity (Quarterly) : 13.47M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.47M |
| March 31, 2026 | 11.75M |
| December 31, 2025 | 15.77M |
| September 30, 2025 | 3.376M |
| June 30, 2025 | 6.353M |
| March 31, 2025 | 4.517M |
| December 31, 2024 | 9.861M |
| September 30, 2024 | 33.91M |
| June 30, 2024 | 28.43M |
| March 31, 2024 | 42.70M |
| December 31, 2023 | 58.63M |
| September 30, 2023 | 10.24M |
| Date | Value |
|---|---|
| June 30, 2023 | 13.08M |
| March 31, 2023 | 19.69M |
| December 31, 2022 | 22.39M |
| September 30, 2022 | 25.73M |
| June 30, 2022 | 20.58M |
| March 31, 2022 | 16.53M |
| December 31, 2021 | 1.447M |
| September 30, 2021 | 2.626M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 4.734M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aprea Therapeutics, Inc. | 39.20M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.43M |
| Total Liabilities (Quarterly) | 2.956M |
| Debt to Equity Ratio | 0.0139 |
| Current Ratio | 2.214 |
| Net Debt Paydown Yield | 45.08% |